Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Epitope identification from fixed-complexity random-sequence peptide microarrays.

Richer J, Johnston SA, Stafford P.

Mol Cell Proteomics. 2014 Nov 3. pii: mcp.M114.043513. [Epub ahead of print]

PMID:
25368412
[PubMed - as supplied by publisher]
Free Article
2.

'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.

Voelz K, Johnston SA, Smith LM, Hall RA, Idnurm A, May RC.

Nat Commun. 2014 Oct 17;5:5194. doi: 10.1038/ncomms6194.

PMID:
25323068
[PubMed - in process]
Free PMC Article
3.

The immunosignature of canine lymphoma: characterization and diagnostic application.

Johnston SA, Thamm DH, Legutki JB.

BMC Cancer. 2014 Sep 8;14:657. doi: 10.1186/1471-2407-14-657.

PMID:
25199568
[PubMed - in process]
Free PMC Article
4.

Scalable high-density peptide arrays for comprehensive health monitoring.

Legutki JB, Zhao ZG, Greving M, Woodbury N, Johnston SA, Stafford P.

Nat Commun. 2014 Sep 3;5:4785. doi: 10.1038/ncomms5785.

PMID:
25183057
[PubMed - in process]
5.

Immunosignature system for diagnosis of cancer.

Stafford P, Cichacz Z, Woodbury NW, Johnston SA.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3072-80. doi: 10.1073/pnas.1409432111. Epub 2014 Jul 14.

PMID:
25024171
[PubMed - indexed for MEDLINE]
6.

Application of immunosignatures for diagnosis of valley fever.

Navalkar KA, Johnston SA, Woodbury N, Galgiani JN, Magee DM, Chicacz Z, Stafford P.

Clin Vaccine Immunol. 2014 Aug;21(8):1169-77. doi: 10.1128/CVI.00228-14. Epub 2014 Jun 25.

PMID:
24964807
[PubMed - in process]
7.

Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.

Sabiiti W, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, Jarvis JN, Gilbert AS, Fisher MC, Harrison TS, May RC, Bicanic T.

J Clin Invest. 2014 May 1;124(5):2000-8. doi: 10.1172/JCI72950. Epub 2014 Apr 17.

PMID:
24743149
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Could immunosignatures technology enable the development of a preventative cancer vaccine?

Shen L, Hansen DT, Johnston SA, Legutki JB.

Expert Rev Vaccines. 2014 May;13(5):577-9. doi: 10.1586/14760584.2014.897616. Epub 2014 Mar 18.

PMID:
24641768
[PubMed - in process]
9.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3.

PMID:
24589717
[PubMed - in process]
Free Article
10.

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies.

Bruce JY, Kolesar JM, Hammers H, Stein MN, Carmichael L, Eickhoff J, Johnston SA, Binger KA, Heideman JL, Perlman SB, Jeraj R, Liu G.

Cancer Chemother Pharmacol. 2014 Mar;73(3):485-93. doi: 10.1007/s00280-013-2373-9. Epub 2014 Jan 12.

PMID:
24414551
[PubMed - indexed for MEDLINE]
11.

Immunosignatures can predict vaccine efficacy.

Legutki JB, Johnston SA.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18614-9. doi: 10.1073/pnas.1309390110. Epub 2013 Oct 28.

PMID:
24167296
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.

Budsberg SC, Stoker AM, Johnston SA, Liska W, Reno LR, Cook JL.

Am J Vet Res. 2013 Sep;74(9):1198-205. doi: 10.2460/ajvr.74.9.1198.

PMID:
23977892
[PubMed - indexed for MEDLINE]
13.

A technology for developing synbodies with antibacterial activity.

Domenyuk V, Loskutov A, Johnston SA, Diehnelt CW.

PLoS One. 2013;8(1):e54162. doi: 10.1371/journal.pone.0054162. Epub 2013 Jan 23.

PMID:
23372679
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cancer goal: Vaccine is cause for optimism.

Johnston SA.

Nature. 2013 Jan 17;493(7432):304. doi: 10.1038/493304c. No abstract available.

PMID:
23325200
[PubMed - indexed for MEDLINE]
15.

Cryptococcus interactions with macrophages: evasion and manipulation of the phagosome by a fungal pathogen.

Johnston SA, May RC.

Cell Microbiol. 2013 Mar;15(3):403-11. doi: 10.1111/cmi.12067. Epub 2012 Nov 30. Review.

PMID:
23127124
[PubMed - indexed for MEDLINE]
16.

Feasibility of an early Alzheimer's disease immunosignature diagnostic test.

Restrepo L, Stafford P, Johnston SA.

J Neuroimmunol. 2013 Jan 15;254(1-2):154-60. doi: 10.1016/j.jneuroim.2012.09.014. Epub 2012 Oct 18.

PMID:
23084373
[PubMed - indexed for MEDLINE]
17.

Minimally displaced tibial tuberosity avulsion fracture in nine skeletally immature large breed dogs.

von Pfeil DJ, Decamp CE, Ritter M, Probst CW, Dejardin LM, Priddy N 2nd, Hayashi K, Johnston SA.

Vet Comp Orthop Traumatol. 2012;25(6):524-31. doi: 10.3415/VCOT-11-12-0170. Epub 2012 Jul 27.

PMID:
22836242
[PubMed - indexed for MEDLINE]
18.

Immunosignaturing can detect products from molecular markers in brain cancer.

Hughes AK, Cichacz Z, Scheck A, Coons SW, Johnston SA, Stafford P.

PLoS One. 2012;7(7):e40201. doi: 10.1371/journal.pone.0040201. Epub 2012 Jul 16.

PMID:
22815729
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Comparative study of classification algorithms for immunosignaturing data.

Kukreja M, Johnston SA, Stafford P.

BMC Bioinformatics. 2012 Jun 21;13:139. doi: 10.1186/1471-2105-13-139.

PMID:
22720696
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Autoreactive antibodies raised by self derived de novo peptides can identify unrelated antigens on protein microarrays. Are autoantibodies really autoantibodies?

Kroening K, Johnston SA, Legutki JB.

Exp Mol Pathol. 2012 Jun;92(3):304-11. doi: 10.1016/j.yexmp.2012.03.002. Epub 2012 Mar 8.

PMID:
22421442
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk